Additional studies are necessary to analyze the inhibitory effect of the ingestion of both the powders on NAFLD progression, in conjunction with more detailed histological evaluation (Oil Red O, CD45, or F4/80 staining, etc.), using animal models of NAFLD that develop steatohepatitis and advancing fibrosis [8]. The gene discussed is PTPRC; the disease is metabolic dysfunction-associated steatotic liver disease.